SeaStar Medical Holding ICU
NASDAQ ICU
$3.35 +0.01 (+0.30%)
At close: Aug 21, 2026 · 4:00 PM EDT

SeaStar Medical Holding (ICU) Accumulated Expenses (2020 - 2026)

SeaStar Medical Holding's (ICU) quarterly Accumulated Expenses came in at $2.9 million in Q1 2026, down 11.0% YoY from $3.3 million in Q1 2025, and up 27.73% on a QoQ basis from $2.3 million in Q4 2025.

SeaStar Medical Holding (ICU) Accumulated Expenses (2020 - 2026) Analysis & Trends

SeaStar Medical Holding (ICU) has 7 years of Accumulated Expenses data on file, last reported at $2.9 million in Q1 2026.

  • Quarterly Accumulated Expenses fell 11.0% year-over-year to $2.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 million (down 11.0% YoY) and the FY2025 annual result came in at $2.3 million, down 28.86% from the prior year.
  • Accumulated Expenses advanced to $2.9 million in Q1 2026, from $2.3 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.3 million in Q1 2025 to a low of $309465.0 in Q1 2022.
  • A 5-year average of $1.7 million and a median of $1.7 million in 2023 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Accumulated Expenses jumped 7056.91% — and 2024, when it tumbled 62.56%.
  • Tracing ICU's Accumulated Expenses over 5 years: stood at $2.2 million in 2022, then sank by 32.16% to $1.5 million in 2023, then surged by 109.32% to $3.2 million in 2024, then slipped by 28.86% to $2.3 million in 2025, then grew by 27.73% to $2.9 million in 2026.
  • The last three Accumulated Expenses figures came in at $2.9 million (Q1 2026), $2.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 SeaStar Medical Holding 13.68 Mn 6.68 Mn 561,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 3.47 Mn
Mar 31, 2026 2.90 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 2.05 Mn
Jun 30, 2025 625,000.00
Mar 31, 2025 3.26 Mn
Dec 31, 2024 3.19 Mn
Jun 30, 2024 856,000.00
Mar 31, 2024 671,000.00
Dec 31, 2023 1.52 Mn
Sep 30, 2023 1.75 Mn
Jun 30, 2023 1.36 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 2.25 Mn
Jun 30, 2022 1.04 Mn
Mar 31, 2022 309,465.00
Dec 31, 2021 58,000.00
Sep 30, 2021 277,306.00
Jun 30, 2021 49,321.00
Mar 31, 2021 4,324.00